|Year : 2021 | Volume
| Issue : 2 | Page : 85-91
Transesophageal echocardiogram in the evaluation of acute ischemic stroke of young adults
Muhammad K Ahmed1, Haris Kamal2, Jessica L Weiss3, Annemarie Crumlish4, Peyman Shirani5, Robert N Sawyer4, Ashkan Mowla6
1 Department of Neurology, Georgia School of Medicine, HCA Education Consortium, Rome, GA; Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA
2 Department of Neurology, New York Medical College, Valhalla, NY, USA
3 Department of Medicine, Division of Cardiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
4 Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA
5 Departments of Neurology and Neurosurgery, University of Cincinnati, Cincinnati, OH, USA
6 Department of Neurological Surgery, Division of Endovascular Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
|Date of Submission||30-Nov-2020|
|Date of Decision||06-Feb-2021|
|Date of Acceptance||22-Feb-2021|
|Date of Web Publication||29-May-2021|
Department of Neurological Surgery, Division of Endovascular Neurosurgery, Keck School of Medicine, University of Southern California, 1200 North State St, Suite 3300, Los Angeles, CA 90033
Source of Support: None, Conflict of Interest: None
INTRODUCTION: Acute ischemic stroke (AIS) in the young age (≤50 years) is a major cause of disability. The underlying mechanism of AIS in this age group is usually different from elderly. Transthoracic echocardiography (TTE) is used to detect the potential cardiac sources of embolism in AIS patients. Transthoracic echocardiogram (TEE) is superior to detect specific underlying cardio-aortic source of embolism when compared to TTE. We aim to evaluate the diagnostic yield and therapeutic impact of TEE in AIS of young adults.
METHODS: We retrospectively reviewed the consecutive patients with AIS in our comprehensive center in a 5-year period from our prospectively collected registry. We selected patients with age ≤50 years who had acute infarcts on brain magnetic resonance imaging or head computed tomography and underwent TEE as part of their diagnostic workup. Demographic details including, age, gender, body mass index, cardiovascular risk factors profile, and TEE findings were collected.
RESULTS: Among a total 7,930 patients, 876 (11.04%) were found to be ≤50 years old. Among those, TEE was done in 113 patients (12.8%) in addition to TTE. Those who underwent TEE had a mean age of 40.4 ± 7.9 years, 60 were male (53%), 7 (6.2%) had a history of coronary artery disease, 38 (33%) had a history of diabetes, and 45 (40%) had a history of smoking. TEE showed new abnormal findings in a total of 15 patients (13.2%) that were not reported in their TTEs. Out of these, left atrial appendage thrombus was found in 5, infective endocarditis in 4, atrial septal aneurysms associated with patent foramen ovale (PFO) in 3, and spontaneous mobile echo density in three patients. Overall, new findings from TEE resulted in change in the secondary stroke prevention strategy in 14 patients of those who underwent TEE (12.3%). TEE also confirmed the presence of PFO, which was present on TTE with bubble study in 20 (17.6%) patients.
CONCLUSION: TEE may provide additional information in the evaluation of the AIS in young adults, which could lead to change of the secondary stroke prevention strategy.
Keywords: Evaluation, stroke, transthoracic echocardiogram, young
|How to cite this article:|
Ahmed MK, Kamal H, Weiss JL, Crumlish A, Shirani P, Sawyer RN, Mowla A. Transesophageal echocardiogram in the evaluation of acute ischemic stroke of young adults. Brain Circ 2021;7:85-91
|How to cite this URL:|
Ahmed MK, Kamal H, Weiss JL, Crumlish A, Shirani P, Sawyer RN, Mowla A. Transesophageal echocardiogram in the evaluation of acute ischemic stroke of young adults. Brain Circ [serial online] 2021 [cited 2023 Jun 6];7:85-91. Available from: http://www.braincirculation.org/text.asp?2021/7/2/85/317205
| Introduction|| |
Acute ischemic stroke (AIS) in young adults with age ≤50 years is a major cause of disability and the rate of AIS in this age group is increasing.,,,,,,,,,,,,,,,, Risk factors and underlying mechanisms for AIS in young adults differ from elderly.,,,, Cardiac sources of embolism contribute to 17%–47% of AIS in young adults, while cryptogenic or undetermined etiology accounts for 19%–40% of AIS in young adults in most population-based studies.,,,, There is no consensus on the optimal diagnostic workup and how to approach AIS with undetermined etiology in young adults. Determination of the underlying mechanism for AIS is pivotal in planning the secondary prevention strategy., Since 2014, the concept of embolic stroke of undetermined source (ESUS) has been introduced, which subclassifies the AIS with undetermined etiology into ESUS based on the presence of nonlacunar type brain infarct on brain imaging, absence of extracranial or intracranial atherosclerosis causing ≥50% luminal stenosis in arteries supplying the area of infarct, absence of cardiac source on transthoracic echocardiogram (TTE), or any other potential underlying mechanisms such as arteritis, arterial dissection, vasospasm, and drug misuse.
Transthoracic echocardiogram (TTE) is generally a part of the diagnostic workup to determine the underlying mechanism for AIS and has a good sensitivity in detecting certain pathologies such as left ventricular thrombi, ventricular aneurysms, certain valvular abnormalities, intracardiac device-associated thrombi, and cardiac tumors. With advancements in imaging modalities, cardiac magnetic resonance imaging (MRI) is also being utilized to detect cardiac source of embolism in AIS. Despite all, transesophageal echocardiogram (TEE) remains a pivotal modality and has been shown to be superior to TTE in detecting certain cardiac and aortic arch pathologies including the left atrial appendage (LAA) pathologies, atrial septal abnormalities such patent foramen ovale (PFO), atrial septal aneurysm (ASA), valve vegetations, intracardiac device-associated thrombi (central venous catheters, pacemaker/implantable cardioverter-defibrillator leads, and prosthetic valves), cardiac tumors, and aortic arch atheroma as potential sources of embolism.
There are limited comparative data available regarding the role of TEE in comparison with TTE to detect the underlying mechanism of AIS in young adult population.
We aimed to study the diagnostic yield of TEE for the detection of underlying mechanism of AIS in young adult patients where our routine diagnostic work (RDW) including TTE was not diagnostic.
| Methods|| |
This is a single-center retrospective study of all consecutive patients who were admitted to our comprehensive stroke center at Buffalo General Medical Center, Buffalo, NY, with the diagnosis of AIS in a 5-year period. Patients who were ≤50 years and had AIS confirmed on their brain MRI/diffusion-weighted imaging or head CT were selected. In our center, these patients generally undergo a RDW for the detection of the underlying mechanism of AIS. RDW in this age group in our center includes laboratory workup including lipid profile and hemoglobin A1c, head computed tomography (CT) without contrast, CT angiogram head and neck, electrocardiogram (EKG) and continuous cardiac rhythm monitoring with automated rhythm detection during the hospital course, MRI of the brain without contrast, and TTE with bubble study. If the patient cannot get CT angiogram of the head and neck for any reason, MR angiogram of the head and neck without contrast or carotid doppler ultrasonography plus transcranial doppler was obtained.
Based on the judgment of the treating of vascular neurologist and particularly when RDW did not reveal any specific underlying mechanism for AIS and the pattern of the acute infarct was thought to be embolic based on the brain imaging, TEE was obtained. In some of these patients and depending on their family history or medical history and if TEE was unremarkable, testing for central nervous system vasculitis and inherited thrombophilia were also obtained, including erythrocyte sedimentation rate and C-reactive protein, antinuclear antibody, rheumatoid factor, complements level, hepatitis B and C serology, lupus anticoagulant, anticardiolipin antibodies, beta-2 glycoprotein antibodies, factor V Leiden mutation, prothrombin gene mutation, protein C, protein S, antithrombin 3, and homocysteine level.
TEE was generally performed by an experienced cardiologist, who was independently performing TEE without active involvement in the stroke care. TEE reports were reviewed carefully by our team member and all the potential cardiac or aortic arch sources for AIS were collected for each patient. For each patient with a potential cardiac or aortic arch source reported on TEE, we reviewed the chart to see whether this new finding has changed the secondary stroke prevention strategy.
In addition to the TEE findings, the demographics and baseline characteristics, i.e., age, gender, race, history of tobacco use, history of recreational drug use, cardiovascular risk factors (hypertension, diabetes mellitus, coronary artery disease, dyslipidemia, prior use of antiplatelets or anticoagulants, personal or family history of thrombophilia, and presenting stroke severity based on the National Institute of Health Stroke Scale), were collected.
| Results|| |
The study population included 7,930 patients with AIS, and out of these, 876 (11.04%) patients were found to be ≤50 years old as shown in [Figure 1]. The baseline characteristics of these patients are summarized in [Table 1].
|Table 1: Baseline characteristics of patients with acute ischemic stroke aged≥50 who had transthoracic echocardiography alone compared to transthoracic echocardiography+transthoracic echocardiogram|
Click here to view
TTE results were available in all these 876 patients. TEE was performed in 113 patients (12.8%) based on the vascular neurologist discretion or suggestion made by a cardiologist performing the TTE. All the patients who underwent TEE already had a TTE obtained during the same hospital course. The baseline characteristics for patients who underwent TEE in addition to TTE are summarized and compared in [Table 1].
TEE resulted in new abnormal findings of potential cardiac or aortic arch sources for AIS in a total of 15 (13.2%) patients when compared to TTE findings. TEE revealed the presence of LAA thrombus in 5 (4.4%), infective endocarditis (IE) in 4 (3.5%), ASA in 3 (2.7%), and a mobile echo density in 3 (2.7%) patients. All patients with abnormal finding of LAA thrombus had sinus rhythm on their EKG and telemetry. TEE also confirmed the presence of PFO, which was present on TTE with bubble study in 20 (17.6%) patients. Overall, new findings from TEE resulted in change in the secondary stroke prevention strategy in 14 (12.3%) patients. These findings led to starting of oral anticoagulation for patients with LAA thrombus or spontaneous mobile echo density in eight patients (7%). New findings of ASA along with PFO resulted in referral for PFO closure in two patients (1.7%). Detection of vegetation resulted in initiation of antibiotic therapy in four patients (3.5%). The new abnormal findings shown on TEE in 15 (13.2%) patients are summarized in [Table 2]. Changes to secondary stroke prevention strategy based on new abnormal findings are summarized in [Table 3].
|Table 3: Secondary stroke prevention strategy changes in patients with new abnormal findings on transthoracic echocardiogram|
Click here to view
| Discussion|| |
The findings of the current study, which included consecutive AIS patients <50 years old from a high-volume comprehensive stroke center, indicated that TEE detected new pathologies in 12.3% of the patients who underwent TEE which changed their secondary stroke prevention strategy. These findings highlight the importance of utility of TEE in AIS patients when RDW is not able to detect the underlying mechanism. Several recent studies have reported that TEE is essential in determining the underlying mechanism in ESUS patients.,,, There are limited data comparing the utility and therapeutic impact of TEE along with TTE compared to TTE alone when RDW does not reveal the underlying mechanism for AIS. Gaudron et al. and Rettig et al. reported that the diagnostic yield of TEE is up to 24%–30% and the therapeutic impact is 10%–12% in patients where initial TTE was unremarkable.
Etiological and diagnostic workup in young adults with AIS includes wide array of tests and differs from elderly due to different risk factors and underlying mechanisms. There is no universally accepted diagnostic work protocol due to limitation of data on cost-effectiveness and diagnostic yield of different tests.,, There is also heterogeneity in the results of the previously published data with the diagnostic tests used for the detection of cardiac sources of embolism rating 20%–47%. The underlying mechanism of AIS in young adults remains unknown after the RDW in at least 35% of the patients in our center. Bang et al. reported that the undetected underlying mechanism for AIS is associated with increased risk of recurrence when compared to AIS with defined underlying mechanisms.
There are different strategies or protocols being utilized at different institutions to improve detection of the cardiac or aortic arch sources for AIS with a different range of cost-effectiveness. However, most of these studies have compared the diagnostic yield of these modalities including TTE, TEE, or cardiac MRI to detect cardiac or aortic arch sources of emboli in AIS patients in all age groups., Only few studies particularly reported the diagnostic yield and therapeutic impact of TEE in young adults with AIS., Two previous studies by de Bruijn et al. and Rettig et al. reported the detection rate of cardiac or aortic arch sources for embolism by TEE in young adults with AIS to be in range of 26%–30%, which is line with the findings of our study.
TEE provides more detailed information about certain structural abnormalities such as PFO, size of PFO, presence of ASA, and also complex aortic arch atheroma compared to TTE. These findings have been associated with increased recurrence of AIS.,, The most common location for thrombus formation in the heart is LAA., TEE provides better understanding of LAA morphology, emptying velocities, and presence or absence of thrombus.,,, Our study reported newly detected LAA thrombus on TEE in 4.4% of the patients who had unremarkable TTE. These findings further changed the secondary stroke prevention strategy in those patients from antiplatelet therapy to anticoagulation. With further studies reporting that the size and structural characteristics of LAA are independent predictors of AIS recurrence, the utility of TEE or multimodal imaging looks even more helpful in the guidance of optimal secondary stroke prevention strategies.,
Previous studies have reported interobserver and intraobserver variability in the detection of abnormalities on TEE (i.e., detection of ASA, morphology of LAA, or spontaneous echo contrast). There are very few studies which defined these echocardiographic findings clearly. These limitations have led to reporting of different rates of findings such as spontaneous mobile echo density, defined as an area of mixed echo density different from the background. This finding is contraindication to mechanical cardioversion and is an indication for oral anticoagulation; however, there is no clear consensus. In our study, TEE detected spontaneous mobile echo density in three patients (2.7%) of those undergoing TEE and all were started on oral anticoagulation.
The prevalence of PFO in young adults with AIS ranged from 24% to 47%, which is reported in a meta-analysis by McGrath et al. Association of PFO with cryptogenic AIS particularly in young adults is a long-standing evolving controversy. Imaging modalities such as TEE with contrast are considered as gold standard for the detection of PFO along with ASA, with one study reporting 100% sensitivity. Currently, TTE with bubble study is being used as the initial diagnostic modality to detect PFO in AIS patients ≤50 years old in our center as it is a noninvasive procedure. TEE is advantageous when compared to TTE as it provides detailed description of the morphology of PFO (i.e., size and shape) and its associated atrial abnormalities such as presence of ASA and intra-aneurysmal thrombus. These associated findings are crucial in risk stratification of PFO in cryptogenic AIS and help in further secondary stroke prevention strategies.,, Recent clinical trials reported that cryptogenic AIS patients with PFO along with structural abnormalities such as ASA are at higher risk of paradoxical emboli and might benefit from PFO closure resulting in lower recurrence rate. Our study confirms that TEE was able to detect ASA associated with PFO in 2.3% of cases. These findings resulted in referral for PFO closure in 2 out of three patients as part of the secondary stroke prevention despite no clear guideline recommendations at the time of patients' management.
IE could be fatal as it has high in-hospital mortality rate with increased risk of cerebral and systemic embolism and could be an underlying mechanism of AIS in young adults. The diagnosis of IE may require TEE, as IE can be missed with TTE., Furthermore, TEE may help assess the risk for septic embolization, which guides further management, i.e., emergent surgical intervention or antibiotic therapy. For example, TEE may provide detailed information about the vegetation size with the size >10 mm being associated with higher risk of embolism. In our study, vegetations were detected in 3.5% of patients who underwent TEE. These findings provoked initiation of antibiotic therapy in four patients.
Nonbacterial endocarditis is associated with an increased risk of thromboembolism, with a rate of approximately 13% in a 4-year follow-up study. TEE is crucial in the detection of nonbacterial endocarditis, particularly in patients with systemic lupus erythematosus. There are also other underlying mechanisms for AIS such as aortic atheroma and atrial myxoma, which are commonly detected on TEE. However, none of these findings was detected in our patients. Studies have reported high sensitivity of TEE in detecting aortic arch atheroma; however, aortic atherosclerosis is generally not common in young adults, consistent with the results of our study.
Our study has a number of limitations. As it is a retrospective study, there is lack of consistent prespecified definitions for abnormal diagnostic findings detected during the study. This study also does not specifically report the particular order of different diagnostic tests performed during the RDW. In addition, the TEE and TTE interpreter experience and number of interpreters involved in reporting these results was not available for reporting.
| Conclusion|| |
TEE carries significant diagnostic yield to determine the underlying mechanism for AIS in young adults and should be considered as part of the workup when no clear mechanism is found with RDW.
We would like to thank Ms. Deborah A. Steck, RN, MS, CNS, SCRN for her valuable and constructive guidance for our data collection.
Declaration of ethical approval and patient consent
The study was approved by the institutional ethics committee (Kaleida Health) in 2013. Patient informed consent was waived since this was a retrospective study and the data were collected anonymously.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, et al
. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: The Helsinki young stroke registry. Stroke 2009;40:1195-203.
Cabral NL, Freire AT, Conforto AB, Dos Santos N, Reis FI, Nagel V, et al
. Increase of stroke incidence in young adults in a middle-income country: A 10-year population-based study. Stroke 2017;48:2925-30.
de Bruijn SF, Agema WR, Lammers GJ, van der Wall EE, Wolterbeek R, Holman ER, et al
. Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke 2006;37:2531-4.
Shahjouei S, Tsivgoulis G, Goyal N, Sadighi A, Mowla A, Wang M, et al
. Safety of intravenous thrombolysis among patients taking direct oral anticoagulants: A systematic review and meta-analysis. Stroke 2020;51:533-41.
Mowla A, Kamal H, Lail NS, Vaughn C, Shirani P, Mehla S, et al
. Intravenous thrombolysis for acute ischemic stroke in patients with thrombocytopenia. J Stroke Cerebrovasc Dis 2017;26:1414-8.
Baher A, Mowla A, Kodali S, Polsani VR, Nabi F, Nagueh SF, et al
. Cardiac MRI improves identification of etiology of acute ischemic stroke. Cerebrovasc Dis 2014;37:277-84.
Kamal H, Mowla A, Farooq S, Shirani P. Recurrent ischemic stroke can happen in stroke patients very early after intravenous thrombolysis. J Neurol Sci 2015;358:496-7.
AbdelRazek MA, Mowla A, Hojnacki D, Zimmer W, Elsadek R, Abdelhamid N, et al
. Prior asymptomatic parenchymal hemorrhage does not increase the risk for intracranial hemorrhage after intravenous thrombolysis. Cerebrovasc Dis 2015;40:201-4.
Mowla A, Singh K, Mehla S, Ahmed MK, Shirani P, Kamal H, et al
. Is acute reperfusion therapy safe in acute ischemic stroke patients who harbor unruptured intracranial aneurysm? Int J Stroke 2015;10 Suppl A100:113-8.
Mowla A, Lail NS, Shirani P. Acute pancreatitis in the setting of acute ischemic stroke. Arch Neurosci 2017;4:e42957.
Mowla A, Shah H, Lail NS, Vaughn CB, Shirani P, Sawyer RN. Statins use and outcome of acute ischemic stroke patients after systemic thrombolysis. Cerebrovasc Dis 2020;49:503-8.
Zambrano Espinoza MD, Lail NS, Vaughn CB, Shirani P, Sawyer RN, Mowla A. Does body mass index impact the outcome of stroke patients who received intravenous thrombolysis? Cerebrovasc Dis 2021;1-6.
Mowla A, Kamal H, Mehla S, Shirani P, Sawyer R. Rate, clinical features, safety profile and outcome of intravenous thrombolysis for acute ischemic stroke in patients with negative brain imaging. J Neurol Res 2020;10:144-5.
Kamal H, Mehta BK, Ahmed MK, Kavak KS, Zha A, Lail NS, et al
. Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis. J Neurol Sci 2021;420:117265.
Mowla A, Doyle J, Lail NS, Rajabzadeh-Oghaz H, Deline C, Shirani P, et al
. Delays in door-to-needle time for acute ischemic stroke in the emergency department: A comprehensive stroke center experience. J Neurol Sci 2017;376:102-5.
Mowla A, Shah H, Lail NS, Shirani P. Successful intravenous thrombolysis for acute stroke caused by polycythemia vera. Arch Neurosci 2017;4:e62181.
Singh K, Mowla A, Mehla S, Ahmed MK, Shirani P, Zimmer WE, et al
. Safety of intravenous thrombolysis for acute ischemic stroke in patients with preexisting intracranial neoplasms: A case series. Int J Stroke 2015;10:E29-30.
Béjot Y, Delpont B, Giroud M. Rising stroke incidence in young adults: More epidemiological evidence, more questions to be answered. J Am Heart Assoc 2016;5:e003661.
Kristensen B, Malm J, Carlberg B, Stegmayr B, Backman C, Fagerlund M, et al
. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 1997;28:1702-9.
Yesilot Barlas N, Putaala J, Waje-Andreassen U, Vassilopoulou S, Nardi K, Odier C, et al
. Etiology of first-ever ischaemic stroke in European young adults: The 15 cities young stroke study. Eur J Neurol 2013;20:1431-9.
George MG, Tong X, Bowman BA. Prevalence of cardiovascular risk factors and strokes in younger adults. JAMA Neurol 2017;74:695-703.
Ji R, Schwamm LH, Pervez MA, Singhal AB. Ischemic stroke and transient ischemic attack in young adults: Risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol 2013;70:51-7.
Ekker MS, Verhoeven JI, Vaartjes I, Jolink WM, Klijn CJ, de Leeuw FE. Association of stroke among adults aged 18 to 49 years with long-term mortality. JAMA 2019;321:2113-23.
Martinez-Majander N, Aarnio K, Pirinen J, Lumikari T, Nieminen T, Lehto M, et al
. Embolic strokes of undetermined source in young adults: Baseline characteristics and long-term outcome. Eur J Neurol 2018;25:535-41.
Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, et al
. Embolic strokes of undetermined source: The case for a new clinical construct. Lancet Neurol 2014;13:429-38.
Gaudron M, Bonnaud I, Ros A, Patat F, de Toffol B, Giraudeau B, et al
. Diagnostic and therapeutic value of echocardiography during the acute phase of ischemic stroke. J Stroke Cerebrovasc Dis 2014;23:2105-9.
McGrath ER, Paikin JS, Motlagh B, Salehian O, Kapral MK, O'Donnell MJ. Transesophageal echocardiography in patients with cryptogenic ischemic stroke: A systematic review. Am Heart J 2014;168:706-12.
Katsanos AH, Bhole R, Frogoudaki A, Giannopoulos S, Goyal N, Vrettou AR, et al
. The value of transesophageal echocardiography for embolic strokes of undetermined source. Neurology 2016;87:988-95.
Umemura T, Nishizawa S, Nakano Y, Saito T, Kitagawa T, Miyaoka R, et al
. Importance of finding embolic sources for patients with embolic stroke of undetermined source. J Stroke Cerebrovasc Dis 2019;28:1810-5.
Ward RP, Don CW, Furlong KT, Lang RM. Racial differences in aortic atheroma in patients undergoing transesophageal echocardiography for unexplained stroke or transient ischemic attack. Am J Cardiol 2004;94:1211-4.
Rettig TC, Bouma BJ, van den Brink RB. Influence of transoesophageal echocardiography on therapy and prognosis in young patients with TIA or ischaemic stroke. Neth Heart J 2009;17:373-7.
Ferro JM, Massaro AR, Mas JL. Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol 2010;9:1085-96.
McMahon NE, Bangee M, Benedetto V, Bray EP, Georgiou RF, Gibson JM, et al
. Etiologic workup in cases of cryptogenic stroke: A Systematic Review of International Clinical Practice Guidelines. Stroke 2020;51:1419-27.
Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol 2003;54:227-34.
Zibaeenezhad MJ, Mowla A, Salahi R, Nikseresht AR, Shariat H, Ashjaezadeh N, et al
. Cardiac sources of embolic cerebral infarction in transesophageal echocardiography. Ann Saudi Med 2006;26:43-5.
] [Full text]
Aggarwal V, Jayachandra A, Aggarwal N, Ahmed F. Study of transesophageal echocardiography in young patients (<40 years) with acute arterial ischemic stroke: A pilot study. Med J Armed Forces India 2020;76:47-50.
Harloff A, Handke M, Reinhard M, Geibel A, Hetzel A. Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke 2006;37:859-64.
Lee JY, Song JK, Song JM, Kang DH, Yun SC, Kang DW, et al
. Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale. Am J Cardiol 2010;106:129-34.
Kent DM, Saver JL, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, et al
. Risk of paradoxical embolism (RoPE)-estimated attributable fraction correlates with the benefit of patent foramen ovale closure: An analysis of 3 trials. Stroke 2020;51:3119-23.
Yaghi S, Song C, Gray WA, Furie KL, Elkind MS, Kamel H. Left atrial appendage function and stroke risk. Stroke 2015;46:3554-9.
Heppell RM, Berkin KE, McLenachan JM, Davies JA. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 1997;77:407-11.
Pirinen J, Järvinen V, Martinez-Majander N, Sinisalo J, Pöyhönen P, Putaala J. Left atrial dynamics is altered in young adults with cryptogenic ischemic stroke: A case-control study utilizing advanced echocardiography. J Am Heart Assoc 2020;9:e014578.
Masci A, Barone L, Dedè L, Fedele M, Tomasi C, Quarteroni A, et al
. The impact of left atrium appendage morphology on stroke risk assessment in atrial fibrillation: A computational fluid dynamics study. Front Physiol 2018;9:1938.
Hussain SI, Gilkeson RC, Suarez JI, Tarr R, Schluchter M, Landis DM, et al
. Comparing multislice electrocardiogram-gated spiral computerized tomography and transesophageal echocardiography in evaluating aortic atheroma in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 2008;17:134-40.
Handke M, Heinrichs G, Moser U, Hirt F, Margadant F, Gattiker F, et al
. Transesophageal real-time three-dimensional echocardiography methods and initial in vitro
and human in vivo
studies. J Am Coll Cardiol 2006;48:2070-6.
Schneider B, Zienkiewicz T, Jansen V, Hofmann T, Noltenius H, Meinertz T. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol 1996;77:1202-9.
Pearson AC, Labovitz AJ, Tatineni S, Gomez CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 1991;17:66-72.
Mazzucco S, Li L, Rothwell PM. Prognosis of cryptogenic stroke with patent foramen ovale at older ages and implications for Trials: A population-based study and systematic review. JAMA Neurol 2020;77:1–9.
Di Salvo G, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP, et al
. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001;37:1069-76.
Bai AD, Steinberg M, Showler A, Burry L, Bhatia RS, Tomlinson GA, et al
. Diagnostic accuracy of transthoracic echocardiography for infective endocarditis findings using transesophageal echocardiography as the reference standard: A meta-analysis. J Am Soc Echocardiogr 2017;30:639-46.e8.
Thuny F, Di Salvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V, et al
. Risk of embolism and death in infective endocarditis: Prognostic value of echocardiography: A prospective multicenter study. Circulation 2005;112:69-75.
Habib G. Embolic risk in subacute bacterial endocarditis: Determinants and role of transesophageal echocardiography. Curr Infect Dis Rep 2005;7:264-71.
[Table 1], [Table 2], [Table 3]